ArticleFrontiers in cell and developmental biology2022

Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy.

Kunpeng Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.